Greenwich LifeSciences reported total assets of $10.51M and total liabilities of $5.24M for the quarter ended Mar 2026, up 281.9% year over year. This balance sheet covers 27 quarters of results from Sep 2019 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 29.80M | 28.91M | 27.20M | 19.74M | 17.19M | 15.64M | 13.47M | 11.91M | 10.94M | 9.14M | 6.99M | 5.51M | 7.22M | 5.82M | 4.09M | 2.75M | 3.13M | 3.81M | 6.18M | 10.51M | |||||||
| Current Assets | 29.80M | 28.91M | 4.09M | 6.18M | 10.51M | ||||||||||||||||||||||
| Non-Current Assets | |||||||||||||||||||||||||||
| Intangibles | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.00M | 0.00M | 0.00M | 0.00M | 876.00 | |||||||||||
| Goodwill & Intangibles | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.00M | 0.00M | 0.00M | 0.00M | 876.00 | |||||||||||
| Other Non-Current Assets | |||||||||||||||||||||||||||
| Non-Current Assets | 0.01M | 0.01M | 0.00M | ||||||||||||||||||||||||
| Assets | 29.82M | 28.92M | 27.22M | 19.75M | 17.20M | 15.65M | 13.48M | 11.92M | 10.95M | 9.15M | 6.99M | 5.51M | 7.23M | 5.83M | 4.09M | 2.75M | 3.13M | 3.81M | 6.18M | 10.51M | |||||||
| Liabilities | |||||||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||||||
| Accounts Payables | 0.63M | 0.30M | 0.22M | 0.22M | 0.22M | 0.22M | 0.22M | 0.22M | 0.30M | 0.23M | 0.26M | 0.35M | 1.34M | 0.77M | 2.80M | 1.05M | 1.30M | 1.11M | 4.87M | 4.51M | |||||||
| Notes Payables | |||||||||||||||||||||||||||
| Payables | 0.63M | 0.30M | 0.22M | 0.22M | 0.22M | 0.22M | 0.22M | 0.22M | 0.30M | 0.23M | 0.26M | 0.35M | 1.34M | 0.77M | 2.80M | 1.05M | 1.30M | 1.11M | 4.87M | 4.51M | |||||||
| Accumulated Expenses | 0.03M | 0.16M | 0.16M | 0.02M | 0.01M | 0.02M | 0.04M | 0.01M | 0.00M | 0.07M | 0.04M | 0.22M | 0.22M | 0.07M | 0.08M | 0.08M | 0.08M | 0.31M | 0.28M | 0.05M | |||||||
| Total Current Liabilities | 0.65M | 0.46M | 0.39M | 0.24M | 0.23M | 0.24M | 0.26M | 0.24M | 0.30M | 0.30M | 0.29M | 0.39M | 1.35M | 0.84M | 3.19M | 1.44M | 1.69M | 1.62M | 5.82M | 5.24M | |||||||
| Non-Current Liabilities | |||||||||||||||||||||||||||
| Other Non-Current Liabilities | 0.31M | 0.31M | 0.31M | 0.67M | 0.67M | ||||||||||||||||||||||
| Total Non-Current Liabilities | 2.88M | 2.24M | 2.21M | 5.15M | 4.56M | ||||||||||||||||||||||
| Total Liabilities | 0.65M | 0.46M | 0.39M | 0.24M | 0.23M | 0.24M | 0.26M | 0.24M | 0.30M | 0.30M | 0.29M | 0.39M | 1.35M | 0.84M | 3.19M | 2.55M | 2.52M | 2.02M | 5.82M | 5.24M | |||||||
| Shareholder's Equity | |||||||||||||||||||||||||||
| Total Debt | |||||||||||||||||||||||||||
| Common Equity | 29.16M | 28.46M | 26.83M | 19.51M | 16.97M | 15.41M | 13.21M | 11.68M | 10.65M | 8.85M | 6.70M | 5.12M | 5.88M | 4.98M | 0.91M | 0.20M | 1.44M | 2.18M | 100.00M | 5.27M | |||||||
| Liabilities and Shareholders Equity | 29.82M | 28.92M | 27.22M | 19.75M | 17.20M | 15.65M | 13.48M | 11.92M | 10.95M | 9.15M | 6.99M | 5.51M | 7.23M | 5.83M | 4.09M | 2.75M | 3.13M | 3.81M | 6.18M | 10.51M | |||||||
| Retained Earnings | 59.57M | 59.74M | -33.65M | -35.62M | -36.36M | -38.68M | -41.47M | -43.60M | -45.23M | -47.62M | -50.36M | -52.84M | -55.44M | -58.11M | -67.78M | -69.41M | -73.44M | -77.59M | -87.14M | -92.79M | |||||||
| Preferred Shares | |||||||||||||||||||||||||||
| Treasury Shares | 0.27M | 0.52M | 0.52M | 0.52M | 0.52M | 0.52M | 0.52M | 0.52M |